It is well documented that women face greater medical exposure to psychotropic drugs than do men, but little research examines whether women also have increased use of prescription drugs with abuse potential. The objectives were to examine gender differences in the use of abusable prescription drugs and to assess how use varies by gender and if patterns of use vary across therapeutic drug classes. With data from the 1987 National Medical Expenditures Survey (NMES), logistic regression analysis is used to model the influence of gender and other sociodemographic and diagnostic variables on the probability of drug use. Women are 48% more likely than men to use any abusable prescription drug, controlling for demographics, health status, economic status, and diagnosis. Additional analyses reveal that being female is a statistically significant predictor of anxiolytic and narcotic analgesic use but not of sedative-hypnotic or stimulant use. Marital status, age, urbanicity, employment status, and having a regular source of care explain gender differences in the use of abusable prescription drugs. Both healthcare and substance abuse treatment providers should be cognizant that women may have greater exposure to these potent prescription medicines. 289 
INTRODUCTION I
T HA S BEEN W ELL DO CU M EN TED that women face greater medical exposure to psychotropic drugs than do men. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Yet little information exists on whether women also have greater use of prescription drugs with abuse potential. Many studies of psychotropic drugs fail to differentiate between abusable (e.g., anxiolytic and sedativehypnotic) and nonabusable (e.g., antidepressant and antipsychotic) therapeutic classes. Further, psychotropic studies often do not include drugs, such as the narcotic analgesics and central nervous system (CNS) stimulants. Thus, although evidence documents gender differences in psychotropic drug use, little of consequence is available on gender differences in the use of abusable prescription drugs. Such analysis is important in understanding if and how women and men differ in the use of abusable prescription drugs and may highlight the need for different approaches to prescription drug abuse detection, prevention, and treatment.
Because of the scarcity of research examining prescription drug abuse, it is not known which factors influence such use. Although not ideal, studies of psychotropic drug use, especially abusable psychotropic classes, may shed light on these gaps. The literature suggests that gender differences in coping with and expressing anxiety and distress, 4, 5, 12, 13 willingness to seek medical care, 1 perceptions of illness, 1 and physician prescribing
Schneider Institute for Health Policy, Brandeis University, Waltham, Massachusetts. bias 3, 10 contribute to women's greater psychotropic use. A recent study affirmed gender differences in the use of anxiolytics and found that predisposing factors responsible for use, such as health insurance status and diagnosis, differ by gender as well. 6 It is important to note that gender, an important determinant of psychotropic drug use, may not be the only significant factor. Other variables predicting drug use include increasing age, socioeconomic status, psychological and social well-being, mental and physical health, psychic distress, and polydrug use. [3] [4] [5] 8, 9, 11, [14] [15] [16] Many of these variables, however, are inextricably linked with gender. For example, inappropriate drug use in elderly women has been well documented. [17] [18] [19] One study presents evidence suggesting that substance abuse, including abuse of prescription drugs, in older women is a growing problem, especially among impoverished and minority women. 20 Other studies suggest that female gender and age together increase the chance of receiving a prescription drug with abuse potential. 18, 21 The purpose of this study is to examine gender differences in the use of abusable prescription drugs. Specifically, this study elicits factors associated with the use of any abusable drug, as well as the use of four therapeutic drug categories with abuse potential-the narcotic analgesics, CNS stimulants, anxiolytics, and sedative-hypnotics. This study assesses whether female abusable prescription drug use equals male use, how correlates of use vary by gender, and whether these patterns are similar across therapeutic drug classes. Findings from this study may inform researchers, policymakers, and providers about gender-sensitive differences in the prevalence, prevention, education, and treatment of prescription drug abuse.
MATERIALS AND METHODS
Data from this study come from the 1987 National Medical Expenditures Survey (NMES), a data collection effort sponsored by the Agency for Health Care Policy and Research (AHCPR). The NMES, which uses a national stratified multistage area probability design, is a survey of the healthcare utilization and expenditures of approximately 14,000 households and 38,446 noninstitutionalized civilian individuals. 22 The sample used in this analysis consists of 22,460 adults . 17 years of age. Of these, 12,392 respondents, or 55.2%, are women.
The primary dependent variable in this analysis is the probability of whether an individual obtained any abusable prescription drug in 1987. This dependent variable is composed of four therapeutic categories of interest-narcotic analgesics (e.g., morphine, acetaminophen with codeine, propoxyphene), CNS stimulants (e.g., amphetamine, methylphenidate), anxiolytic agents (e.g., diazepam, alprazolam, triazolam), and sedativehypnotics (e.g., secobarbital, phenobarbital, chloral hydrate). Each of these therapeutic categories is analyzed as a separate dependent variable. The drug categories represent prescription drugs deemed to have abuse potential by the Drug Enforcement Agency (DEA). 23 The system used for processing prescribed medicine data was originally developed for another federal data collection effort and is described elsewhere. 24 Selection of explanatory variables and covariates predicting abusable prescription drug use was guided by earlier studies [1] [2] [3] [4] 6, 11 and from review literature. 7, 14, 20 The independent variable of interest is gender, with male as the reference category. Other demographic variables include race (nonwhite is reference), age groups 18-24, 25-34, and $ 65 (35-64 is reference), marital status (nonmarried is reference), geographic location (rural is reference), and education (less than high school education is reference). Socioeconomic covariates include employment status (unemployed is reference), health insurance status (uninsured is reference), whether the individual has a regular source of care (no regular source is reference), and poor/fair health status (good/excellent health status is reference).
In addition to sociodemographic variables, the analysis controls for diagnoses, which are self-reported conditions subsequently coded into International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) codes. Up to four diagnostic codes per medication are collected in NMES. The diagnoses used in this analysis are selected based on their association with the use of the four categories of abusable drugs, as documented by literature and medical compendia. Thus, mental illness includes all self-reports of depression, neurosis (primarily anxiety), psychalgia, psychoses, and other psychiatric conditions. Physical illness includes those conditions associated with the use of the types of abusable
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prescription drugs, such as cardiovascular disease, arthritis, back pain, cancer, insomnia, fatigue, and obesity. The reference category is all remaining diagnoses.
Logistic regression analysis is used to estimate the probability of abusable prescription drug use. The probability of overall drug use is evaluated, as are the use of the four classes of abusable prescription drugs. For those analyses in which gender is statistically significant, separate logistic regression equations for men and women are estimated to elicit the factors that vary by gender.
As described, the explanatory variables incorporated in predicting overall drug use and drug use within each therapeutic category include gender, age, race, urbanicity, marital status, educational attainment, employment status, availability of health insurance, regularity of healthcare, health status, and mental and physical health status variables. For overall drug use, diagnoses are coded into two categorical variables-any mental diagnosis and any physical diagnosis. In predicting the probability of any therapeutic drug class use, specific diagnoses germane to the drugs of interest are included. For example, diagnoses in which narcotic analgesics are therapeutic agents are incorporated into the model predicting the probability of narcotic analgesic use. Thus, mental diagnoses of psychalgia and physical diagnoses of arthritis, back pain, and cancer are reported in estimating the probability of any narcotic analgesic use. Parallel models are estimated, without the inclusion of gender as an independent variable, in the probability of drug use by each gender for those drug classes in which gender is statistically significant.
In these analyses, full-model estimates are used with all explanatory variables in order to demonstrate statistically significant and insignificant associations with the dependent variables. Odds ratios (OR) and 95% confidence intervals (CI) are reported for all predictor variables in the model that have a p value # 0.05. Goodness-of-fit is assessed using the chi 2 -distributed log likelihood test. 25 SAS statistical software is used to analyze the data.
26

RESULTS
Bivariate analysis reveals that males and females differ along a number of variables (Table  1) . Relative to men, women tend to be significantly older than 65 years of age (24.5% versus 20.4%), nonwhite (30.7% versus 28.5%), single (46.4% versus 34.9%) and less well educated (68.7% versus 64.8%). In addition, women are significantly less likely than men to be employed (50.6% versus 68.7%). Despite lower levels of employment, however, women are significantly more likely than men to have a regular source of care (83.5% versus 74.7%) and have health insurance (83.3% versus 79.3%). Although women appear to have better medical care access than men, they report significantly poorer health (26.6% versus 22.3%). Women tend to report significantly more mental and physical conditions of all types, with the exception of psychosis and gastroin-GENDER AND ABUSABLE PRESCRIPTION DRUGS 291 Separate logistic regression equations are estimated to determine if gender differences persist in the use of each therapeutic category. Analyses reveal that gender is not a statistically significant predictor of sedative-hypnotic or stimulant use but does play a role in influencing the use of narcotic analgesics and anxiolytics. The findings for these latter two therapeutic categories are reported in Table 3 .
Logistic regression analysis shows that the probability of receiving any narcotic analgesic is 41% greater for women than men (CI 5 To further elucidate how men and women differ in the use of abusable prescription drugs, separate logistic regression equations are estimated for each therapeutic category in which gender is a statistically significant explanatory variable. For ease of interpretation, Table 4 compares the OR and associated 95% CI only for those explanatory variables that differ by gender in statistical significance or direction at p # 0.05.
Although many variables similarly predict any There are also significant gender differences in narcotic analgesic use. For instance, married men are 39% more likely (CI 5 1.16, 1.66) to use narcotics than are single men; once again, marital status plays no role in predicting narcotic use by women. Employed women, on the other hand, are 85% as likely to use narcotic analgesics as are unemployed women (CI 5 0.74, 0.96), whereas employment status has no bearing on male narcotic use. Finally, females with a regular source of care are 38% more likely than females without regular care to receive any narcotic analgesic (CI 5 1.16, 1.63), although having a regular source of care is not significant for males.
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Married men are 40% more likely to engage in anxiolytic use than are their single peers (CI 5 1.06, 1.86). In addition, men aged $ 65 years are 72% as likely (CI 5 0.54, 0.96) to use anxiolytics as younger men. Neither marital status nor older age influence females' probability of anxiolytic use.
DISCUSSION
This study demonstrates that women are more likely than men to use an abusable prescription drug. Controlling for diagnosis, demographic variables, health insurance, and health status, being female increases the odds of using any abusable prescription drug by 48% relative to being male. However, women do not use more of all types of abusable prescription drugs; rather, women are more likely than men to use narcotics and anxiolytics.
Gender is not the only significant variable predicting abusable prescription drug use. Not surprisingly, those who are employed are significantly less likely to use these potent drugs, perhaps because they are healthier than their unemployed peers. Having financial access in the form of health insurance and having a regular source of care also increase the probability of drug use. Those who reported poor or fair health, a proxy for severity-of-illness, also are more likely to use prescription drugs with abuse potential.
Although this analysis demonstrates that being white (rather than nonwhite) increases the probability of any abusable drug use, as well as the use of anxiolytics and narcotics, other studies have found the influence of race to be questionable. Several studies have found that nonwhites receive significantly fewer psychoactive drugs than whites, 6 narcotic analgesics than their white peers. [28] [29] [30] Further analysis of racial and ethnic differences is needed to clarify this issue.
Of interest is the finding that age varies in significance and direction by therapeutic category. Those aged 25-34 are significantly more likely and those aged $ 65 are less likely to use any abusable prescription drug relative to their middle-aged (34-65) peers. When looking at each therapeutic category separately, however, this pattern generally does not hold. Anxiolytic users tend to be middle-aged , and narcotic users tend to be , 35. The elderly across all drug categories are significantly less likely to use abusable drugs relative to those aged 35-64. This latter finding is of considerable interest, as a number of researchers have suggested that elderly people are particularly susceptible to exposure to psychotropic drugs in general 4, [17] [18] [19] [20] and anxiolytics in particular. 8, 11 Other studies, however, have shown either no such association between psychotropic drug use and advancing age 6 or that psychotropic drug use peaks at middle age and then declines subsequently. 31 Diagnoses, which also vary by gender, are highly predictive of abusable drug use. This analysis, however, does not necessarily suggest that drug use parallels disease prevalence. For example, although the lifetime prevalence rate of anxiety is more than two times higher in women than men (1.8% versus 0.8%, respectively), 32 this study finds that women are only 51% more likely than men to use an anxiolytic. Thus, unless physicians are systematically misdiagnosing physical and mental conditions in men and women, differences in disease prevalence alone do not explain gender differences in the prescribing of abusable prescription drugs.
The variables predicting abusable prescription drug use are essentially the same for men and women. There are some subtle gender differences, however, that require further explanation. Most notably, marital status appears to make a difference by gender, with married men more likely to use any abusable prescription drug, narcotic analgesics and anxiolytics than unmarried men, and with marital status having no real effect on women's use of drugs. Whether married men are under more stress or suffer more illness than their single peers, or are encouraged by their spouses to seek treatment for conditions that use potentially abusable prescribed medicines, are questions subject to further analysis.
It is likely that gender differences in the use of abusable prescription drugs may lie in intervening paths. For example, women and men may differ in their propensity to identify and report conditions that may require treatment with an abusable prescription drug. Men and women may also differ in their propensity to seek care in the first place. Several studies, however, confirm that women's higher psychotropic use rates remain after controlling for office visits. 3, 33 It is not clear what role the medical use of abusable prescription drugs play in their actual abuse and dependency. Some researchers suggest that opiate-naive people receiving narcotics for chronic medical conditions rarely become addicted to these substances. 34, 35 There are no data that prove or disprove that addiction to prescription drugs is primarily precipitated by prescriptions received in a medical context. Only one study to date has described both medical and nonmedical use of prescription drugs. 36 However, the study did not attempt to examine the relationships between medical and nonmedical use or the factors explaining such use.
The study has several limitations. For one, physician specialty is unknown, and several studies have shown that physician specialty influences the amount and type of drugs prescribed. 6,28,37,3 8 Further, the study does not estimate patient access to physician care, which other research suggests is an important determinant of prescription drug use. 3, 28 The gender of the prescribing physician also is unknown; some studies suggest that the interaction between physician gender and patient gender may influence the amounts and types of treatments provided by physicians. 39, 40 In addition, the data are over a decade old. Unfortunately, the 1987 NMES is the only database available to examine personlevel prescription drug use,* and this analysis represents the most current examination of gender differences in drug prescribing. Research using the National Ambulatory Medical Care Survey (NAMCS), a survey of office-based physician visits conducted annually, has shown that office visits resulting in any psychotropic prescription increased from 32.7 million in 1985 to 45.6 million in 1994. 41 This same study also showed that
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*At the time of this analysis, the necessary data files of the Medical Expenditures Panel Survey (MEPS) were not yet publicly available. The MEPS uses more recent data (1996) and is the latest version of the NMES series. anxiolytic use had declined over time but was only surpassed by the use of antidepressant medications. Findings from the NAMCS suggest that, if anything, the use of any abusable prescription drugs may be an even greater problem now, with the possible exception of anxiolytic use. No studies, however, have examined the use of narcotic analgesics over time.
This study is also limited by the use of respondent self-reported data, which may result in underreporting. In particular, self-report of mental health diagnoses may be suspect because of the stigma that is often associated with behavioral conditions. However, underreporting is unlikely to be a significant problem with the NMES as a result of the care taken by NMES data collectors in interviewer training, questionnaire design, adjustments for missing responses, and the use of respondent diaries to prevent recall errors. 42 Specifically, a random sample of diagnoses was verified using claims and medical records, and comparability was quite high. 42 Prescribed medicine information was obtained directly from the dispensing package. 16 This study demonstrates that, controlling for diagnosis, sociodemographics, and other factors, women are at increased risk for use of abusable prescription drugs. Specifically, this study shows that women may be at increased risk for the use of two types of abusable prescribed drugs, narcotic analgesics and anxiolytics. What this study does not do is look at the actual misuse or abuse of prescription drugs. Instead, it examines the use of prescription drugs that have serious potential for abuse. Further exploration is necessary; specifically, analysis of the gender role in the context of prescription drug misuse and abuse should be conducted. Other research should examine the possibility that women with abuse tendencies choose prescription drugs over the illicit drugs and alcohol favored by men. It is important to determine whether medical exposures to potentially abusable prescription drugs is a gateway to their actual abuse, and if propensity to abuse varies by gender. If medical exposure is a pathway to problem use or abuse, detection, prevention, and intervention approaches can be developed for use by physicians and other health and medical professionals. Just as important is research that examines whether gender differences in the use of abusable prescription drugs are clinically or socially relevant and whether men and women are receiving sufficient, safe, and appropriate prescription drug care.
